Brief: Gabather AB Submits Clinical Trial Application To Further Advance Development Of GT-002
Jan 22 (Reuters) - Gabather AB GABAT.ST :
* GABATHER AB SUBMITS A CLINICAL TRIAL APPLICATION TO
FURTHER
ADVANCE THE DEVELOPMENT OF GT-002
* GABATHER- SUBMITTED APPLICATION TO REGULATORY AUTHORITIES
IN
PORTUGAL FOR DOUBLE-BLIND, PLACEBO CONTROLLED MULTIPLE ASCENDING
DOSES CLINICAL TRIAL
Source text for Eikon: ID:nWkr5vdRqY
Further company coverage: GABAT.ST
((Reuters.Briefs@thomsonreuters.com;))